Education
About Us
Working with TipRanks
Follow Us
BioGaia AB Class B (GB:0GTN)
LSE:0GTN
0GTN Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr93.60 - kr134.60
Previous CloseN/A
Volume2.49K
Average Volume (3M)6.19K
Market Cap
kr11.06B
Enterprise Valuekr10.12B
Total Cash (Recent Filing)kr622.34M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)38.3
Beta0.52
Next Earnings
Oct 22, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.87
Shares Outstanding98,497,170
10 Day Avg. Volume6,969
30 Day Avg. Volume6,190
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
kr115.00Price Target Upside6.72% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
BioGaia AB News
0GTN FAQ
What was BioGaia AB Class B’s price range in the past 12 months?
BioGaia AB Class B lowest share price was kr93.60 and its highest was kr134.60 in the past 12 months.
What is BioGaia AB Class B’s market cap?
BioGaia AB Class B’s market cap is kr11.06B.
When is BioGaia AB Class B’s upcoming earnings report date?
BioGaia AB Class B’s upcoming earnings report date is Oct 22, 2025 which is in 24 days.
How were BioGaia AB Class B’s earnings last quarter?
BioGaia AB Class B released its earnings results on Jul 18, 2025. The company reported kr0.87 earnings per share for the quarter, missing the consensus estimate of kr0.927 by -kr0.057.
Is BioGaia AB Class B overvalued?
According to Wall Street analysts BioGaia AB Class B’s price is currently Undervalued.
Does BioGaia AB Class B pay dividends?
BioGaia AB Class B does not currently pay dividends.
What is BioGaia AB Class B’s EPS estimate?
BioGaia AB Class B’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioGaia AB Class B have?
BioGaia AB Class B has 98,497,170 shares outstanding.
What happened to BioGaia AB Class B’s price movement after its last earnings report?
BioGaia AB Class B reported an EPS of kr0.87 in its last earnings report, missing expectations of kr0.927. Following the earnings report the stock price went down -6.98%.
Which hedge fund is a major shareholder of BioGaia AB Class B?
Currently, no hedge funds are holding shares in GB:0GTN
Company Description
BioGaia AB Class B
BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylorithe gastric ulcer bacterium; and low bone density. It offers its products under the BioGaia brand name. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.
Technical Analysis
Options Prices
Currently, No data available
---